• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉出血热:病原体特性及疫苗与化疗药物的研发

Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents.

作者信息

Kiselev O I, Vasin A V, Shevyryova M P, Deeva E G, Sivak K V, Egorov V V, Tsvetkov V B, Egorov A Yu, Romanovskaya-Romanko E A, Stepanova L A, Komissarov A B, Tsybalova L M, Ignatjev G M

机构信息

1Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, 197376 Russia.

2St. Petersburg State Polytechnic University, St. Petersburg, 195251 Russia.

出版信息

Mol Biol. 2015;49(4):480-493. doi: 10.1134/S002689331504007X. Epub 2015 Aug 14.

DOI:10.1134/S002689331504007X
PMID:32214474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7089462/
Abstract

Ebola hemorrhagic fever (EHF) epidemic currently ongoing in West Africa is not the first among numerous epidemics in the continent. Yet it seems to be the worst EHF epidemic outbreak caused by Ebola virus Zaire since 1976 as regards its extremely large scale and rapid spread in the population. Experiments to study the agent have continued for more than 20 years. The EHF virus has a relatively simple genome with seven genes and additional reading frame resulting from RNA editing. While being of a relatively low genetic capacity, the virus can be ranked as a standard for pathogenicity with the ability to evade the host immune response in uttermost perfection. The EHF virus has similarities with retroviruses, but belongs to (-)RNA viruses of a nonretroviral origin. Genetic elements of the virus, NIRV, were detected in animal and human genomes. EHF virus glycoprotein (GP) is a class I fusion protein and shows more similarities than distinctions in tertiary structure with SIV and HIV gp41 proteins and even influenza virus hemagglutinin. EHF is an unusual infectious disease, and studying the molecular basis of its pathogenesis may contribute to new findings in therapy of severe conditions leading to a fatal outcome.

摘要

目前在西非肆虐的埃博拉出血热疫情并非非洲大陆众多疫情中的首例。然而,就其在人群中的大规模爆发和快速传播而言,它似乎是自1976年以来由扎伊尔埃博拉病毒引发的最严重的埃博拉出血热疫情。对该病原体的研究实验已经持续了20多年。埃博拉出血热病毒的基因组相对简单,有七个基因以及由RNA编辑产生的额外阅读框。尽管其遗传能力相对较低,但该病毒在完美逃避宿主免疫反应方面堪称致病性的典范。埃博拉出血热病毒与逆转录病毒有相似之处,但属于非逆转录起源的(-)RNA病毒。在动物和人类基因组中检测到了该病毒的遗传元件NIRV。埃博拉出血热病毒糖蛋白(GP)是一种I类融合蛋白,在三级结构上与SIV和HIV gp41蛋白甚至流感病毒血凝素相比,相似之处多于差异。埃博拉出血热是一种罕见的传染病,研究其发病机制的分子基础可能有助于在导致致命后果的严重疾病治疗方面取得新发现。

相似文献

1
Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents.埃博拉出血热:病原体特性及疫苗与化疗药物的研发
Mol Biol. 2015;49(4):480-493. doi: 10.1134/S002689331504007X. Epub 2015 Aug 14.
2
[Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents].[埃博拉出血热:病原体特性及疫苗与化学治疗剂的研发]
Mol Biol (Mosk). 2015 Jul-Aug;49(4):541-54. doi: 10.7868/S0026898415040072.
3
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.阿比多尔和其他抑制拉沙病毒和埃博拉病毒的低分子量药物。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02185-18. Print 2019 Apr 15.
4
Ebola hemorrhagic fever (EHF): mechanism of transmission and pathogenicity.埃博拉出血热(EHF):传播机制与致病性
J Nippon Med Sch. 2001 Oct;68(5):370-5. doi: 10.1272/jnms.68.370.
5
Ebola hemorrhagic Fever and the current state of vaccine development.埃博拉出血热与疫苗研发的现状
Osong Public Health Res Perspect. 2014 Dec;5(6):378-82. doi: 10.1016/j.phrp.2014.09.006. Epub 2014 Nov 1.
6
Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.埃博拉出血热疫情:有效疫情管理、遏制与控制策略
Braz J Infect Dis. 2015 May-Jun;19(3):308-13. doi: 10.1016/j.bjid.2015.02.004. Epub 2015 Apr 17.
7
Addressing the Threat of Emerging Viral Infections.应对新出现的病毒感染的威胁。
Keio J Med. 2023;72(1):27. doi: 10.2302/kjm.ABSTRACT_72_1-2.
8
A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.一种在 2013-2016 年埃博拉病毒流行期间出现的糖蛋白突变改变了蛋白水解作用并加速了膜融合。
mBio. 2021 Feb 16;12(1):e03616-20. doi: 10.1128/mBio.03616-20.
9
A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.埃博拉病毒糖蛋白内部融合环内的一种多态性调节宿主细胞进入。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.00177-17. Print 2017 May 1.
10
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.基于痘病毒的埃博拉病毒表达 GP 和 VP40 蛋白疫苗候选物的免疫原性和疗效的差异。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.

本文引用的文献

1
Development of therapeutics for treatment of Ebola virus infection.埃博拉病毒感染治疗药物的研发。
Microbes Infect. 2015 Feb;17(2):109-17. doi: 10.1016/j.micinf.2014.11.012. Epub 2014 Dec 11.
2
Ebola virus disease in West Africa--clinical manifestations and management.西非埃博拉病毒病——临床表现与治疗
N Engl J Med. 2014 Nov 27;371(22):2054-7. doi: 10.1056/NEJMp1413084. Epub 2014 Nov 5.
3
Clinical presentation and management of severe Ebola virus disease.严重埃博拉病毒病的临床表现与管理
Ann Am Thorac Soc. 2014 Nov;11(9):1341-50. doi: 10.1513/AnnalsATS.201410-481PS.
4
A case of severe Ebola virus infection complicated by gram-negative septicemia.严重埃博拉病毒感染合并革兰氏阴性菌败血症病例报告。
N Engl J Med. 2014 Dec 18;371(25):2394-401. doi: 10.1056/NEJMoa1411677. Epub 2014 Oct 22.
5
Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.丝状病毒参考序列条目:丝状病毒类型变体、类型序列及名称的评估与选择
Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.
6
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.西非埃博拉病毒病——疫情头9个月及未来预测
N Engl J Med. 2014 Oct 16;371(16):1481-95. doi: 10.1056/NEJMoa1411100. Epub 2014 Sep 22.
7
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak.基因组监测解析了 2014 年埃博拉疫情期间病毒的起源和传播。
Science. 2014 Sep 12;345(6202):1369-72. doi: 10.1126/science.1259657. Epub 2014 Aug 28.
8
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.黑猩猩腺病毒疫苗可产生针对埃博拉病毒挑战的急性和持久保护免疫。
Nat Med. 2014 Oct;20(10):1126-9. doi: 10.1038/nm.3702. Epub 2014 Sep 7.
9
Ebola drug trials set to begin amid crisis.埃博拉药物试验在危机中即将开始。
Nature. 2014 Sep 4;513(7516):13-4. doi: 10.1038/513013a.
10
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.非人灵长类动物中的马尔堡病毒感染:脂质包裹的小干扰RNA的治疗性处理
Sci Transl Med. 2014 Aug 20;6(250):250ra116. doi: 10.1126/scitranslmed.3009706.